Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 5/20 | 0.66 |
| ▸ | MEN1 | O00255 | 4/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.66 |
| ▸ | NPC1 | O15118 | 3/20 | 0.66 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.62 |
| ▸ | CASP3 | P42574 | 1/20 | 0.57 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | MITF | O75030 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.56 |
| ▸ | GABRP | O00591 | 4/20 | 0.55 |
| ▸ | GABRD | O14764 | 4/20 | 0.55 |
| ▸ | GABRA1 | P14867 | 4/20 | 0.55 |
| ▸ | GABRB1 | P18505 | 4/20 | 0.55 |
| ▸ | GABRG2 | P18507 | 4/20 | 0.55 |
| ▸ | GABRB3 | P28472 | 4/20 | 0.55 |
| ▸ | GABRA5 | P31644 | 4/20 | 0.55 |
| ▸ | GABRA3 | P34903 | 4/20 | 0.55 |
| ▸ | GABRA2 | P47869 | 4/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28511881 | 0.93 | NR4A2 (0.65) | RAB9AMEN1KMT2ANPC1NR4A2 | |
| SCHEMBL28519317 | 0.88 | MAPT (0.60) | RAB9AMEN1KMT2ANPC1NR4A2 | |
| SCHEMBL11924588 | 0.85 | RAB9A (0.76) | RAB9AMEN1KMT2ANPC1CASP3 | |
| SCHEMBL28519299 | 0.85 | NR4A2 (0.58) | RAB9AMEN1KMT2ANPC1NR4A2 | |
| SCHEMBL28521278 | 0.85 | NR4A2 (0.58) | RAB9AMEN1KMT2ANR4A2MAPT | |
| SCHEMBL28511912 | 0.84 | NR4A2 (0.57) | RAB9AMEN1KMT2ANPC1NR4A2 | |
| SCHEMBL14554210 | 0.84 | MEN1 (0.60) | RAB9AMEN1KMT2ANPC1CASP3 | |
| SCHEMBL13042958 | 0.84 | RAB9A (0.72) | RAB9AMEN1KMT2ANPC1NR4A2 | |
| SCHEMBL11924916 | 0.83 | GABRP (0.71) | NR4A2GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL24906134 | 0.83 | NR4A2 (0.70) | RAB9AMEN1KMT2ANR4A2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140155626-A1 | MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2014-06-05 | — | — | US | disclosed |
| US-20130011923-A1 | MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2013-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140155626-A1 | MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS | CFTR, ABCB1, ABCC2 | RAB9A 2302/4885MEN1 4698/4885KMT2A 4344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.